Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection

BACKGROUND: Recombinant insulin Lisargine is a new type of insulin. In this study, we aimed to compare its pharmacodynamic (PD) and pharmacokinetic (PK) with Lantus. METHODS: The PD test was performed by exploring the effect of single administration on blood glucose of normal rats and STZ-induced di...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jiangjie, Zeng, Yong, Yi, Xiulin, Zhang, Hongmei, Zhu, Lin, Jiang, Lixin, Li, Jing, Zhou, Wei, Zhu, Hong, Xiong, Aijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653765/
https://www.ncbi.nlm.nih.gov/pubmed/33167951
http://dx.doi.org/10.1186/s12906-020-03110-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653765/
https://www.ncbi.nlm.nih.gov/pubmed/33167951
http://dx.doi.org/10.1186/s12906-020-03110-3

Ejemplares similares